Hepatoma

Hepatoma, also known as hepatocellular carcinoma, is the most common type of primary liver cancer. It begins in the cells of the liver and can spread to other parts of the body. Risk factors for developing hepatoma include long-term infection with the hepatitis B or C virus, cirrhosis, long-term alcohol abuse, diabetes, and some inherited conditions. Symptoms of hepatoma may include abdominal pain, jaundice, a mass or lump in the belly, and weight loss. Diagnosis of hepatoma typically involves imaging tests such as a CT scan or MRI, and possibly a biopsy. Treatment options vary depending on the size and stage of the tumor. Surgery to remove the tumor is the most common option, and may be combined with chemotherapy and/or radiation therapy. Other treatments may include targeted drug therapy, ablation therapy, and immunotherapy. Hepatoma is an aggressive form of cancer, so it is important to catch it at an early stage. Early detection and regular monitoring are key to improving the prognosis and outcome for those with this condition. Regular check-ups and screenings can help to identify any changes in the liver, which can be signs of hepatoma.